Last CNY21.68 CNY
Change Today -0.41 / -1.86%
Volume 6.3M
002390 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

guizhou xinbang pharmaceut-a (002390) Snapshot

Open
CNY22.10
Previous Close
CNY22.09
Day High
CNY22.20
Day Low
CNY21.35
52 Week High
03/6/14 - CNY27.90
52 Week Low
10/10/13 - CNY10.44
Market Cap
10.8B
Average Volume 10 Days
7.1M
EPS TTM
CNY0.19
Shares Outstanding
500.5M
EX-Date
06/16/14
P/E TM
114.9x
Dividend
CNY0.03
Dividend Yield
0.14%
Current Stock Chart for GUIZHOU XINBANG PHARMACEUT-A (002390)

Related News

No related news articles were found.

guizhou xinbang pharmaceut-a (002390) Related Businessweek News

No Related Businessweek News Found

guizhou xinbang pharmaceut-a (002390) Details

Guizhou Xinbang Pharmaceutical Co., Ltd. is engaged in the research, development, manufacture, and distribution of Chinese patent medicines in China. The company provides medicines primarily for the treatment of cardio cerebral vascular diseases and digestive system diseases. It also offers urinary system medicines, anti-infective drugs, antipyretic analgesics, gynecological medication, calcium medication, anti-cold medication, and endocrine medicines. The company provides its products in tablet, capsule, and granule forms. Guizhou Xinbang Pharmaceutical Co., Ltd. was founded in 1995 and is based in Guiyang, China.

Founded in 1995

guizhou xinbang pharmaceut-a (002390) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

guizhou xinbang pharmaceut-a (002390) Key Developments

Guizhou Xinbang Pharmaceutical Co., Ltd. Proposes Amendment to the Articles of Association

Guizhou Xinbang Pharmaceutical Co., Ltd. at its extraordinary general meeting to be held on September 19, 2014, proposed amendments to the company's article of association.

Guizhou Xinbang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Sep 19, 2014

Guizhou Xinbang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Sep 19, 2014., at 14:30 China Standard Time. Agenda: To consider the eligibility for non-public share offering; to consider the connected transitions involved in the non-public share offering; to consider scheme for non-public share offering; to consider preplan for non-public share offering; to consider feasibility report on use of proceeds from the non-public share offering; to consider authorization to the board to handle matters in relation to non-public share offering; to sign conditional share subscription contract with a limited partnership; to sign conditional share subscription contract with subscription parties; to consider amendments to the company's articles of association; to consider formulation of the plan for the shareholders profit return for the next three years(2014-2016); to consider amendments to the raised fund management system; to consider amendments to the company's rules of procedures governing shareholders' general meetings; and to report on use of previously raised funds.

Guizhou Xinbang Pharmaceutical Co., Ltd. to Report First Half, 2014 Results on Aug 27, 2014

Guizhou Xinbang Pharmaceutical Co., Ltd. announced that they will report first half, 2014 results on Aug 27, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002390:CH CNY21.68 CNY -0.41

002390 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002390.
View Industry Companies
 

Industry Analysis

002390

Industry Average

Valuation 002390 Industry Range
Price/Earnings 100.0x
Price/Sales 10.4x
Price/Book 4.8x
Price/Cash Flow 159.8x
TEV/Sales 7.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUIZHOU XINBANG PHARMACEUT-A, please visit www.xinbang.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.